Special Issue: Heart Failure in the ElderlyClinical ResearchCognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEF
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
The WARCEF trial was supported by U.S. National Institute of Neurological Disorders and Stroke (NINDS) grants U01-NS-043975 (to Dr. Homma) and U01-NS-039143 (to Dr. Thompson). Dr. Anker is a consultant for Bayer, Boehringer Ingelheim, Novartis, Stealth Peptides, Servier, Vifor, and Janssen; and has received research support from Abbott Vascular and Vifor. Dr. Homma is a consultant for St. Jude Medical, Daiichi-Sankyo, Bristol-Myers Squibb, and Pfizer. Dr. Labovitz has received research support from Bristol-Myers Squibb/Pfizer. Dr. Lip is a consultant for Bayer/Janssen, Bristol-Myers Squibb/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Novartis, Verseon, and Daiichi-Sankyo; and is a speaker for Bayer, Bristol-Myers Squibb/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. Dr. Sacco has received research support from grants from NINDS, National Center for Advancing Translational Sciences, American Heart Association, the Evelyn McKnight Brain Foundation, and Boehringer Ingelheim. Dr. Teerlink is a consultant for and has received research support from Actelion, Amgen, Bayer, Cytokinetics, Medtronic, Novartis, St. Jude Medical, and Trevena. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.